Typical antipsychotic drugs -: D2 receptor occupancy and depressive symptoms in schizophrenia

被引:68
作者
Bressan, RA
Costa, DC
Jones, HM
Ell, PJ
Pilowsky, LS
机构
[1] Inst Psychiat, London SE5 8AF, England
[2] UCL, Sch Med, Inst Nucl Med, London W1N 8AA, England
关键词
schizophrenia; depression; dopamine; D-2; receptors; single photon emission tomography;
D O I
10.1016/S0920-9964(01)00185-2
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
We tested the hypothesis that the degree of striatal dopamine D-2 receptor blockade induced by typical antipsychotic treatment directly correlates with the presence and severity of depressive symptoms in schizophrenia. Clinical and [I-123]-IBZM Single photon emission tomography (SPET) scan data obtained from 18 typical antipsychotic treated schizophrenic patients was analysed to evaluate the relationship between striatal D, receptor occupancy and the depressive subscale of the Brief Psychiatric Rating Scale (BPRS-D). Striatal D-2 receptor occupancy by typical antipsychotic drugs was significantly positively correlated with BPRS-D scores (r = 0,52, p = 0.025). This study suggests that high striatal dopamine D-2 blockade by typical antipsychotic drugs may contribute to the emergence of depressive symptoms in typical antipsychotic treated schizophrenic patients. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:31 / 36
页数:6
相关论文
共 24 条
  • [1] RELIABILITY AND VALIDITY OF A DEPRESSION RATING-SCALE FOR SCHIZOPHRENICS
    ADDINGTON, D
    ADDINGTON, J
    MATICKATYNDALE, E
    JOYCE, J
    [J]. SCHIZOPHRENIA RESEARCH, 1992, 6 (03) : 201 - 208
  • [2] DRUG-INDUCED MOOD DISORDERS
    ANANTH, J
    GHADIRIAN, AM
    [J]. INTERNATIONAL PHARMACOPSYCHIATRY, 1980, 15 (01): : 59 - 73
  • [3] Bressan RA, 1998, SCHIZOPHR RES, V32, P41
  • [4] BRESSAN RA, 1999, J PSYCHOPHARMACOL, V13, pA17
  • [5] BRUCKE T, 1991, J CEREBR BLOOD F MET, V11, P220
  • [6] IN VIVO CHARACTERISATION OF 3-IODO-6-METHOXYBENZAMIDE I-123 IN HUMANS
    COSTA, DC
    VERHOEFF, NPLG
    CULLUM, ID
    ELL, PJ
    SYED, GMS
    BARRETT, J
    PALAZIDOU, E
    TOONE, B
    VANROYEN, E
    BOBELDIJK, M
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1990, 16 (11): : 813 - 816
  • [7] Subjective experience and striatal dopamine D2 receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone
    de Haan, L
    Lavalaye, J
    Linszen, D
    Dingemans, PMAJ
    Booij, J
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (06) : 1019 - 1020
  • [8] ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766
  • [9] THE CAUSALITY OF DEPRESSION IN SCHIZOPHRENIA
    GALDI, J
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1983, 142 (JUN) : 621 - 625
  • [10] DEPRESSION IN SCHIZOPHRENIA - ARE NEUROLEPTICS, AKINESIA, OR ANHEDONIA INVOLVED
    HARROW, M
    YONAN, CA
    SANDS, JR
    MARENGO, J
    [J]. SCHIZOPHRENIA BULLETIN, 1994, 20 (02) : 327 - 338